In a strategic move to enhance its global presence, Sphere Bio has significantly expanded its distributor network across Asia-Pacific markets. This initiative aims to provide researchers with cutting-edge microfluidics technology and localized support, marking a crucial step in the company's mission to drive scientific innovation.

Empowering Global Research Through Advanced Technology

The biotechnology landscape is witnessing a transformative shift, thanks to Sphere Bio’s commitment to expanding access to its groundbreaking single-cell analysis platforms. By forging alliances with top-tier distributors, the company is ensuring that its innovative solutions reach more scientists and institutions across diverse regions.

Strengthening Regional Alliances

Sphere Bio has solidified its position in key Asian and Pacific markets by partnering with renowned organizations such as 1st PhileKorea, AS ONE Corporation, Decode Science, Everlife Research Instruments, and Premas Life Sciences. These collaborations not only broaden the company’s reach but also deepen its understanding of regional needs. Each distributor brings unique expertise and local knowledge, enabling Sphere Bio to tailor its offerings effectively.Moreover, these partnerships underscore Sphere Bio’s dedication to fostering long-term relationships within the scientific community. The addition of new distributors complements existing ones like Bang Trading, Cold Spring Biotech, and Gene Company, creating a comprehensive network that spans multiple territories. Such an extensive framework ensures seamless delivery of products and services while enhancing customer satisfaction.

Driving Innovation With Next-Generation Platforms

At the heart of Sphere Bio’s expansion lies its state-of-the-art Cyto-Mine® Chroma platform, which sets new standards in functional single-cell analysis. This advanced system offers unparalleled precision and efficiency, empowering researchers to unlock complex biological processes at unprecedented scales. Alongside this flagship product, the company continues to roll out novel assays designed to meet evolving research demands.By investing in robust infrastructure and forming strategic alliances, Sphere Bio positions itself as a leader in delivering transformative solutions for life sciences. Its commitment to innovation resonates throughout its portfolio, driving adoption rates higher and establishing trust among users worldwide. As demand surges globally, the company remains steadfast in its pursuit of excellence through continuous improvement and adaptation.

Commitment to Customer Success

Dale Levitzke, CEO of Sphere Bio, emphasizes the significance of 2025 as a turning point for scaling operations and entering high-growth markets. According to him, aligning with best-in-class distributors amplifies the company’s ability to deliver exceptional value to customers around the world. This collaborative approach reflects Sphere Bio’s unwavering focus on accelerating scientific discovery through technological advancement.In addition, Jay Manikandan, VP Commercial (APAC), highlights how the enhanced distributor network reinforces the company’s pledge to offer personalized customer support tailored to specific regional requirements. By bringing their solutions closer to end-users, Sphere Bio fosters greater engagement and collaboration, ultimately propelling advancements in the field of single-cell analysis.

Fueling Future Discoveries

As Sphere Bio continues to expand its footprint across the Asia-Pacific region, it lays the groundwork for groundbreaking discoveries that could reshape our understanding of biology and medicine. The integration of next-generation technologies into everyday laboratory workflows promises to streamline processes, reduce costs, and improve accuracy—all critical factors in achieving meaningful breakthroughs.Furthermore, the company’s proactive stance in addressing regional challenges demonstrates its adaptability and responsiveness to changing market dynamics. By prioritizing customer-centric strategies and leveraging expert partnerships, Sphere Bio cements its role as a catalyst for progress in the life sciences sector.